| Blood–brain barrier breakdown in relationship to Alzheimer and vascular disease Z Lin, S Sur, P Liu, Y Li, D Jiang, X Hou, J Darrow, JJ Pillai, S Yasar, ... Annals of neurology 90 (2), 227-238, 2021 | 62 | 2021 |
| Quantitative proteomic analysis of the frontal cortex in Alzheimer’s disease G Sathe, M Albert, J Darrow, A Saito, J Troncoso, A Pandey, A Moghekar Journal of neurochemistry 156 (6), 988-1002, 2021 | 47 | 2021 |
| Brain oxygen extraction is differentially altered by Alzheimer's and vascular diseases D Jiang, Z Lin, P Liu, S Sur, C Xu, K Hazel, G Pottanat, J Darrow, JJ Pillai, ... Journal of Magnetic Resonance Imaging 52 (6), 1829-1837, 2020 | 36 | 2020 |
| Multiplexed phosphoproteomic study of brain in patients with Alzheimer's disease and age-matched cognitively healthy controls G Sathe, KK Mangalaparthi, A Jain, J Darrow, J Troncoso, M Albert, ... Omics: a journal of integrative biology 24 (4), 216-227, 2020 | 25 | 2020 |
| Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease SK Byeon, AK Madugundu, AP Jain, FA Bhat, JH Jung, S Renuse, ... Molecular omics 17 (3), 454-463, 2021 | 23 | 2021 |
| CSF Alzheimer Disease Biomarkers: Time-Varying Relationships With MCI Symptom Onset and Associations With Age, Sex, and ApoE4 BD Greenberg, C Pettigrew, A Soldan, J Wang, MC Wang, JA Darrow, ... Neurology 99 (15), e1640-e1650, 2022 | 12 | 2022 |
| CSF Biomarkers predict gait outcomes in idiopathic normal pressure hydrocephalus JA Darrow, A Lewis, S Gulyani, K Khingelova, A Rao, J Wang, Y Zhang, ... Neurology: Clinical Practice 12 (2), 91-101, 2022 | 5 | 2022 |
| Effect of Patient-Specific Preanalytic Variables on CSF Aβ1–42 Concentrations Measured on an Automated Chemiluminescent Platform JA Darrow, A Calabro, S Gannon, A Orusakwe, R Esquivel, CJ Traynham, ... The journal of applied laboratory medicine 6 (2), 397-408, 2021 | 4 | 2021 |
| Reassessing accuracy of blood cell correction factor for traumatic lumbar puncture GT Kannarkat, J Darrow, A Moghekar Journal of the Neurological Sciences 432, 120097, 2022 | 2 | 2022 |
| In an optimized CSF collection protocol the pTau181/Aβ1-42 ratio increases preanalytical variability over measuring Aβ1-42 alone R Esquivel, S Ho, J Darrow, A Calabro, P Thakker, S Gannon, ... Poster session presented at: 15th Clinical Trials on Alzheimer’s Disease …, 2022 | 1 | 2022 |
| Assessment of Preanalytical Cerebrospinal Fluid Handling and Storage Factors on Measurement of Aβ1-42, Aβ1-40, and pTau181 Using an Automated Chemiluminescent Platform S Ho, J Darrow, F De Simone, A Calabro, S Gannon, R Esquivel, ... The Journal of Applied Laboratory Medicine, jfae033, 2024 | | 2024 |
| Quantitative Dissection of Healthy Aging and Early Cognitive Decline Using Proteoform Signatures from Paired CSF and Plasma M Tognetti, C Messner, R Bruderer, D Kamber, J Darrow, A Lewis, ... MOLECULAR & CELLULAR PROTEOMICS 21 (8), S65-S65, 2022 | | 2022 |
| CSF SNAP‐25 dynamics in healthy aging and across the spectrum of Alzheimer's disease A Lewis, JA Darrow, Y Zhang, AJ Ball, M Mendes, A Jeromin, A Moghekar Alzheimer's & Dementia 17, e057662, 2021 | | 2021 |
| CSF biomarkers predict long term improvement after shunt surgery for Idiopathic Normal Pressure Hydrocephalus (4211) A Lewis, J Darrow, A Moghekar Neurology 96 (15 Supplement), 2021 | | 2021 |
| This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading … G Tao, C Auvrez, R Nightscales, S Barnard, L Mccartney, CB Malpas, ... | | 2021 |
| P4‐476: EFFECT OF PATIENT‐SPECIFIC PRE‐ANALYTIC VARIABLES ON CSF Aβ42 CONCENTRATIONS MEASURED ON AN AUTOMATED CHEMILUMINESCENT PLATFORM JA Darrow, A Calabro, S Gannon, A Orusakwe, R Esquivel, CJ Traynham, ... Alzheimer's & Dementia 15, P1494-P1494, 2019 | | 2019 |
